Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Dr Bethan Lang at Downing Street
Dr Bethan Lang at Downing Street

Epilepsy Research UK, the only charity in the UK solely dedicated to the funding of research into the causes, prevention and treatment of epilepsy, is celebrating its 20th year. To celebrate the occasion ERUK recently held the 'million pound grant round' to fund new projects and fellowships. Drs Bethan Lang, Sarosh Irani and Jane Adcock (Nuffield Department of Clinical Neurosciences) were honoured to be awarded one of these project grants.

To honour their success, Dr Bethan Lang was invited to 10 Downing Street on the evening of 22nd May to meet Samantha Cameron and other dignitaries involved in Epilepsy Research in the UK.

In a previous ERUK-funded project, Bethan’s team had demonstrated that a small, but significant, number of patients with epilepsy harboured specific autoantibodies to CNS ion channels, receptors and accessory proteins that may be involved in the development of epilepsy. In this newly awarded study, which will be funded by the ERUK for three years, they will be recruiting new onset patients with focal epilepsies from throughout the Thames Valley area to look for both the already established antibodies and  to investigate autoantibodies to novel cell-surface autoantibodies.  Patients with focal epilepsies will be studied specifically in this project and they will attempt to define the clinical phenotypes associated with the presence of circulating autoantibodies and follow the patients during treatment.

Similar stories

Capturing immune cells that colonise the brain to prevent disease progression in multiple sclerosis

Clinical Neurology Research

Researchers have revealed a disease-causing population of immune cells, which travel to the brain in patients with multiple sclerosis. They demonstrate how to trap these cells in the blood, which means they can be targeted to prevent disease progression.

Two neurologists awarded MRC Senior Clinical Fellowships

Clinical Neurology Research

Two of our Associate Professors, Sarosh Irani and George Tofaris, have been awarded MRC Senior Clinical Fellowships.

Developing diagnostics for COVID-19

Clinical Neurology Coronavirus Research

Associate Professor Sarosh Irani, who heads up our Autoimmune Neurology Group, has been funded by Mologic to help develop diagnostics for COVID-19.

COVID-19 and Guillain-Barré syndrome

Clinical Neurology Coronavirus Research

Multiple recent case reports have suggested a link between COVID-19 and Guillain-Barré syndrome (GBS), an acute, disabling, immune-mediated disorder of the peripheral nervous system. It is currently unclear whether this simply represents a chance association.

Viruses shown to evolve as a result of different immune responses in different ethnic populations

Clinical Neurology Coronavirus Research

New research into the HIV-1 virus has shed light on an important factor in the evolution of viruses, which is likely also to affect SARS-CoV-2 (the virus which causes COVID-19). This new insight could have important implications for vaccine development.

Emerging Leaders Prize celebrates outstanding pain researchers

Award Clinical Neurology

2020’s Emerging Leaders Prize awards £200,000 to outstanding scientists from the University of Oxford, University College London and King’s College London, who are all working in the field of pain research.